CRMD (US) share price forecast & AI signal — CorMedix Inc

Week of 2026-10-30 · Healthcare

This week's AI signal
BUY
Confidence: High (exact % inside)
3-month: BUY · 1-month: BUY · 1-week: BUY
Last close · 2026-11-06
$5.32
1 wk -6.7% · 1 mo -27.3%
Unlock the full CRMD forecast

Exact confidence, 1-week / 1-month / 3-month breakdown, plain-English AI write-up, bull-vs-bear debate, support & resistance.

Get 5 free tokens — no card Already a member? Open the full analysis

What the model sees in CRMD

CorMedix Inc is a Healthcare stock listed on the US. For the week of 2026-10-30 the ACE machine-learning model rates it a BUY with high confidence, based on technical indicators and the stock's own historical patterns across three time horizons. The direction is updated every model run.

About CorMedix Inc

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Recent closes

DateClose
2026-11-06$5.32
2026-11-05$5.23
2026-11-04$5.66
2026-11-03$5.56
2026-11-02$5.39
2026-10-30$5.70
2026-10-29$7.64

CRMD FAQ

Is CorMedix Inc (CRMD) a buy or sell this week?

The ACE Stock Bots machine-learning model rates CRMD a BUY for the week of 2026-10-30 with high confidence. The exact confidence and the 1-week, 1-month and 3-month breakdown are free with a signup (5 analysis tokens, no card).

What is the AI share price forecast for CRMD?

Every week the model scores CRMD across three horizons using technical indicators and the stock's own historical patterns. An AI then writes a plain-English summary with support and resistance levels, and a bull analyst and a bear analyst argue the case.

Is this financial advice?

No. ACE Stock Bots provides general information generated by software. It does not consider your objectives, financial situation or needs. Read the disclaimer and consider licensed advice before acting.

Other Healthcare stocks on the US

LLYJNJABBVUNHMRKAZNNVSAMGN

This week's top US picks · All US stocks

Signals are generated by software for general information only and are not a recommendation to buy or sell. See the disclaimer.